Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor...

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Schizophrenia is increasingly viewed as a disorder of dynamic neural processes.
• Altered N-methyl-d-aspartate (NMDA) receptor signaling is implicated in schizophrenia pathophysiology.
• Understanding the genetic and molecular underpinnings of these neural dynamics is crucial.

Purpose of the Study:

• To investigate alterations in brain network flexibility in individuals with schizophrenia and their relatives.
• To examine the impact of N-methyl-d-aspartate (NMDA) receptor hypofunction on network flexibility.
• To identify a potential dynamic network intermediate phenotype for schizophrenia genetic liability.

Main Methods:

• Functional magnetic resonance imaging (fMRI) combined with dynamic network neuroscience techniques.
• Quantification of "network flexibility" during working memory tasks.
• Pharmacological challenge with dextromethorphan to antagonize NMDA receptors in healthy controls.

Main Results:

• Significant differences in network flexibility were observed across patients with schizophrenia, their relatives, and healthy controls, correlating with genetic risk.
• Network flexibility was significantly increased by NMDA receptor antagonism with dextromethorphan.
• These findings suggest a link between NMDA receptor function, network flexibility, and schizophrenia liability.

Conclusions:

• Altered brain network flexibility represents a potential intermediate phenotype for schizophrenia.
• This phenotype is influenced by N-methyl-d-aspartate (NMDA) receptor function.
• Glutamate's role in temporal neural coordination is critical in schizophrenia pathophysiology.